‌

US Patent 8105842 Interleukin-13 as a cardiovascular disease marker

Patent 8105842 was granted and assigned to Saga University on January, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Saga University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8105842

Date of Patent

January 31, 2012

Patent Application Number

11355089

Date Filed

February 16, 2006

Patent Primary Examiner

‌

Lorraine Spector

Patent abstract

The present invention relates to use of interleukin-13 as a cardiovascular disease marker. The therapeutic composition and diagnostic composition of the invention for cardiovascular diseases are characterized by comprising an antibody to an interleukin-13 receptor and/or an antibody to interleukin-13.